BiotechTube
Home/Lokon Pharma/Angelica Loskog
AL

Angelica Loskog

CEO / Chief Scientific Officer

Lokon Pharma

Therapeutic Areas

Oncology

Lokon Pharma Pipeline

DrugIndicationPhase
LOAd703 (LOKON001)Pancreatic CancerPhase 1/2
LOAd703 (LOKON002)Pancreatic, Biliary, Ovarian, Colorectal CancerPhase 1/2
LOAd703 (LOKON003)Malignant MelanomaPhase 1/2

Leadership Team at Lokon Pharma

GU
Gustav Ullenhag
Principal Investigator (LOKON003)
View full Lokon Pharma profile